Other studies analyzed the IL-6 expression in tumor tissue, plasma and bronchoalveolar lavage, and found a correlation with progression, resistance to anti-tumor therapies and poor survival of patients with lung cancer [7,39,40]. The gene discussed is IL6; the disease is lung cancer.